Krystal Biotech, Inc. (KRYS)
238.55
+3.91
(+1.67%)
USD |
NASDAQ |
Dec 10, 13:16
Krystal Biotech Market Cap: 6.917B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 54.03B |
| Vanda Pharmaceuticals, Inc. | 387.67M |
| ADMA Biologics, Inc. | 4.731B |
| Aldeyra Therapeutics, Inc. | 286.37M |
| ACADIA Pharmaceuticals, Inc. | 4.553B |
Market Cap Related Metrics
| PE Ratio | 35.78 |
| PS Ratio | 19.07 |
| PEG Ratio | 0.1291 |
| Price to Book Value | 6.079 |
| Price to Free Cash Flow | 42.98 |
| Price | 238.55 |
| Earnings Yield | 2.79% |
| PEGY Ratio | 0.1291 |
| Operating PE Ratio | 44.98 |
| Normalized PE Ratio | 35.78 |